How many acquisitions has Johnson & Johnson made so far?

Johnson & Johnson has completed 60 acquisitions so far, with an average acquisition amount of $3.73B.

Which countries does Johnson & Johnson usually acquire in?

Johnson & Johnson has made acquisitions in 8 countries with the most activity in United States and Israel.

In which year did Johnson & Johnson make the most acquisitions?

Johnson & Johnson was most active in 2018, with 5 acquisitions completed in that year.

List of 60 Acquisitions by Johnson & Johnson (Jun 2026)

Q: Which is Johnson & Johnson's latest acquisition?

Johnson & Johnson's most recent acquisition is Firefly Bio, a Developer of antibody drug conjugates for the treatment of cancer, acquired in June 2026 for $1B.

Most viewed in 2019

Johnson & Johnson has completed a total of 60 acquisitions. Peak acquisition years include 2018 with 5 acquisitions, and 2025 and 2024 each with 4 acquisitions. Acquisition activity has spanned 8 countries, notably United States with 47 acquisitions, along with Israel and Switzerland each having 3. These activities have involved 35 sectors, with the highest numbers in Cardiac and Vascular Disorders (7), Immunotherapy (7), and Oncology (5). The average number of acquisitions per year over the last five years (2020–2025) is 2, and 2 acquisitions have been completed in the current calendar year. The most recent acquisition was Firefly Bio, a developer of antibody drug conjugates for cancer treatment. Founded in 2022 and located in San Francisco, Firefly Bio was acquired for $1B in June 2026.

Here's the year on year acquisition history of Johnson & Johnson:

Number of Total Acquisitions

Year	# Acquisitions
2026	2
2025	4
2024	4
2023	1
2022	1
2020	1
2019	3
2018	5
2017	3
2016	3
2015	2
2014	1
2012	2
2010	4
2009	2
2008	4
2007	1
2006	2
2005	2
2004	1
2003	2
2001	1
2000	1
1999	2
1997	2
1995	1
1994	1
1961	2

View all Acquisitions by Johnson & Johnson

Recent acquisitions by Johnson & Johnson

Johnson & Johnson's most recent acquisition - Firefly Bio is a Developer of antibody drug conjugates for the treatment of cancer, founded in 2022 and located in San Francisco. Johnson & Johnson acquired it in June 2026 for a price of $*****.

Here is the list of all acquisitions by Johnson & Johnson sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Jun 08, 2026	Firefly Bio	iaky	mfbg	75	485
Apr 24, 2026	Atraverse Medical	qcpm	wceb	50	941
Nov 17, 2025	Halda Therapeutics	igbk	thel	66	156
Sep 04, 2025	OBaris	ooeh	dgqa	61	393
Jul 25, 2025	Erickson-Larsen, Inc. and Bjornson/Sentinel-E&L	jckg	psaf	25	622